Gyang_Tirisham_460x460

Assistant Professor - Clinical

Department of Neurology

Division of Multiple Sclerosis and Neuroimmunology

395 W 12th Ave, 7th floor
Columbus, OH 43210
tirisham.gyang@osumc.edu
Twitter - @TirishamGyangMD

Research Interests

  • Experimental therapeutics in multiple sclerosis and neuroimmunology
  • Neurotoxicity related to cancer immunotherapy including CAR T and immune check point inhibitors.
  • COVID-19 vaccination in patients with multiple sclerosis
  • Quality of life in multiple sclerosis

Background

Dr. Tirisham Gyang is an assistant clinical professor with the Ohio State University Wexner Medical Center where she serves as a clinician and the program director for the multiple sclerosis fellowship program. She specializes in Multiple Sclerosis and related neuro-immunological disorders of the brain and spinal cord and has particular interest in experimental therapeutics, clinical trials and medical education. She serves as the principal investigator in multiple clinical trials and clinical research projects. As the fellowship director for the MS/neuroimmunology program, she trains aspiring MS specialists in comprehensive clinical care and clinical research. In addition to her interest in multiple sclerosis and demyelinating disorders, she has established multi-disciplinary clinics in neuro-rheumatology and neurosarcoidosis.

Dr. Gyang is passionate about empowering patients with personalized inter-disciplinary clinical care, quality education and clinical research.

She completed her training in clinical multiple sclerosis and experimental therapeutics from University of Rochester Medical Center as a scholar of the National MS society. She is board certified neurologist and is an active member of multiple professional societies.

Highlights

  • Fellowship directory, MS/neuroimmunology
  • Vice Chair Diversity Equity and Inclusion – Department of neurology

Education

Fellowship: Experimental therapeutics fellowship
Neuroimmunology and Multiple sclerosis
National Multiple Sclerosis Society (NMSS) Scholar
University of Rochester Medical Center, Rochester, NY

Residency: Neurology, SUNY Upstate Medical University, Syracuse, NY

Internship: Internal Medicine, SUNY Upstate Medical University, Syracuse, NY

Medical school: St George’s University School of Medicine
Keith B. Taylor Global Scholars’ Program
Grenada
Northumbria University, Newcastle, UK
Diploma of Higher Education in Medical Sciences

Undergraduate: St Louis University, St Louis, MO
Bachelor of Arts in Biology

Clinical Trials

A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with primary progressive multiple sclerosis (PERSEUS).

A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio®) in participants with relapsing forms of multiple sclerosis (GEMINI 1).

PubMED articles
My clinical profile

Subscribe. Get just the right amount of health and wellness in your inbox.